作者: Ivan Horak , Puja Sapra
DOI:
关键词:
摘要: New methods of treating Ras associated cancer, and especially for cancer that is resistant or refractory to other treatment methods, including with C225 and/or CPT-11, are provided. The new employ PEG-conjugated 7-ethyl-10-hydroxycampothecin, alone, in combination art-known anticancer agents modalities.